Citation Impact
Citing Papers
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
Cardiovascular and Metabolic Alterations in Mice Lacking Both β1- and β2-Adrenergic Receptors
1999 StandoutNobel
Role of the Frank-Starling mechanism in maintaining cardiac output during increasing levels of treadmill exercise in beta-blocked normal men
1989
Nontuberculous mycobacteria in the setting of cystic fibrosis
2002
AIDS-Related Mycobacterium kansasii Infection with Initial Resistance to Clarithromycin
1998
Pulmonary Disease Due to Nontuberculous Mycobacteria
2008
Aerosolized amikacin for treatment of pulmonary Mycobacterium aviuminfections: an observational case series
2007
A longitudinal study of respiratory changes in normal human pregnancy with cross-sectional data on subjects with pregnancy-induced hypertension
1990
Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems
2010
Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease
2014
Mitogen-activated protein kinase pathways
1997 Standout
Mycobacterium avium Complex Pulmonary Disease: Incidence, Presentation, and Response to Therapy in a Community Setting
1991
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
The therapeutic approach to non-tuberculous mycobacterial infection of the lung
2010
Repeat Positive Cultures inMycobacterium intracellulareLung Disease after Macrolide Therapy Represent New Infections in Patients with Nodular Bronchiectasis
2002
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
2011 Standout
The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells
2005
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
2010 Standout
Qualitative and Quantitative Drug-susceptibility Tests in Mycobacteriology
1988
Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease
2013
Structural Basis for the Antibiotic Activity of Ketolides and Azalides
2003 StandoutNobel
Mycobacterium avium complex Pulmonary Disease in Patients Without HIV Infection
2004
Antibiotic Treatment of Mycobacterium abscessus Lung Disease
2009
Clinical Significance of Nontuberculous Mycobacteria Isolated From Respiratory Specimens in Korea
2006
Nontuberculous Mycobacterial Infection in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
2004
Ribosomal antibiotics: structural basis for resistance, synergism and selectivity
2004 StandoutNobel
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
Oral Macrolide Therapy Following Short-term Combination Antibiotic Treatment of Mycobacterium massiliense Lung Disease
2016
Sulfate Metabolism in Mycobacteria
2006 StandoutNobel
Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria
1990 Standout
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Prognostic Factors of 634 HIV-Negative Patients with Mycobacterium avium Complex Lung Disease
2011
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013
2016 Standout
Nontuberculous Mycobacteria
2003
The Macrolides: Erythromycin, Clarithromycin, and Azithromycin
1999
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Phonon spectroscopy
1988
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G
2005 StandoutNobel
Drug Susceptibility Testing of Nontuberculous Mycobacteria
2014
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis
2015
Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria
2012
Ethambutol Pharmacokinetic Variability Is Linked to Body Mass in Overweight, Obese, and Extremely Obese People
2011
Basic anatomical and physiological data for use in radiological protection: reference values
2002 Standout
Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease
2016
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
Alterations in dynamic heart rate control in the β1-adrenergic receptor knockout mouse
1998 StandoutNobel
Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure.
1995
Pathophysiology of Sleep Apnea
2010 Standout
Phonon spectroscopy
1983
Infection Source and Epidemiology of Nontuberculous Mycobacterial Lung Disease
2018 Standout
Infections due to non-tuberculous mycobacteria (NTM).
2004
ANTIBIOTICS TARGETING RIBOSOMES: Resistance, Selectivity, Synergism, and Cellular Regulation
2005 StandoutNobel
Clinical Significance and Epidemiologic Analyses of Mycobacterium avium and Mycobacterium intracellulare among Patients without AIDS
2005
Surviving the Acid Test: Responses of Gram-Positive Bacteria to Low pH
2003 Standout
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium
1997 Standout
Thermal boundary resistance
1989 Standout
The Mycobacterium avium complex
1993
Crohn's disease and the mycobacterioses: a review and comparison of two disease entities
1989
Works of D. T. Murphy being referenced
Azithromycin Activity Against Mycobacterium avium Complex Lung Disease in Patients Who Were Not Infected with Human Immunodeficiency Virus
1996
Early Results (at 6 Months) with Intermittent Clarithromycin-Including Regimens for Lung Disease Due to Mycobacterium avium Complex
2000
Rifampin-Resistant Mycobacterium kansasii
1994
Polyclonal Mycobacterium avium Complex Infections in Patients with Nodular Bronchiectasis
1998
A NON-INVASIVE METHOD FOR MEASURING CARDIAC OUTPUT: THE EFFECT OF CHRISTMAS LUNCH
1986
Multiple-ion phonon absorption in Al2O3:Cr2+
1979
A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex.
1986
PHONON SPECTROSCOPY OF CHROMIUM-DOPED GALLIUM ARSENIDE USING SUPERCONDUCTING TUNNEL JUNCTIONS
1981
THE PHONON SPECTROSCOPY OF DOPED MAGNESIUM OXIDE USING SUPERCONDUCTING TUNNEL JUNCTIONS
1978
An investigation of V3+ion pairs in Al2O3by phonon spectroscopy
1979
Phonon spectroscopy of chromium-doped GaAs using superconducting tunnel junctions
1982